Nuo Therapeutics Company Description

Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States.

The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market.

It serves hospital outpatient wound care clinics and other private practice physicians treating chronic wounds.

The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014.

Nuo Therapeutics, Inc. was incorporated in 1998 and is based in Houston, Texas.

Nuo Therapeutics, Inc.

Country	United States
Founded	1998
Industry	Biotechnology
Sector	Healthcare
Employees	9
CEO	David Jorden

Contact Details

Address: 8285 El Rio Houston, Delaware 77054 United States
Phone	(346) 396-4770
Website	nuot.com

Stock Details

Ticker Symbol	AURX
Exchange	OTCMKTS
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US67059V2097
SIC Code	2836

Key Executives

Name	Position
David E. Jorden CPA	Chief Executive Officer, Chief Financial Officer, Secretary and Executive Director
Dr. Peter Anton Clausen Ph.D.	Chief Operating Officer and Chief Scientific Officer
Joseph A. Del Guercio	Informal Board Advisor